Neuphoria Therapeutics Inc 20-F for FY2022
Neuphoria Therapeutics Inc. (NEUP)
20-F
2022-10-14
For: 2022-06-30
View Original
Added on
April 07, 2026
About this 20-F
Neuphoria Therapeutics Inc filed this 20-F on October 14, 2022, covering the fiscal year ended June 30, 2022 (FY2022).
Headline figures
Fiscal year ended June 30, 2022, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- 263.63K AUD
- Net income
- 913.37K AUD
- up 2.3% from net income of 892.51K AUD a year earlier
- Diluted EPS
- -0.02 AUD
- compared with -0.01 AUD a year earlier